Loading clinical trials...
Loading clinical trials...
Low back pain (LBP) is an extremely common problem that most people experience at some point in their life. It is the leading cause of activity limitation and work absence throughout much of the world. In India, occurrence of LBP is also alarming. Nearly 60% of the population has significant back pain at some time in their life. In Brazil, spinal pain (cervical, thoracic and lumbar) was considered the second most prevalent complaint, affecting approximately 13.5% of the population. It is estimated that globally 39% of the population will have at least one episode of back pain throughout their lives. In episodes of pain greater than 12 weeks (classified as chronic lower back pain), the prognosis is unfavorable and is highly associated with high treatment costs and work absenteeism. Non-specific low back pain" \[NSLBP\] is defined as, low back pain that is not attributable to a recognizable or known specific pathology - bone disorder in the spine \[fracture\], radicular nerve compression, slipped intervertebral disk, stenosis in lumbar spine, inflammatory disorder of spine \[ankylosing spondylitis\], cauda equine syndrome, congenital back disorder, infection in the spine \[discitis\], tumour in lumbar area, osteoporosis, meningitis, Cancer, HIV, autoimmune disorder \[RA\].
HYPOTHESIS: Null hypothesis: There is significant effects of dry needling with conventional physiotherapy treatment as compared to Kinesio Taping with conventional physiotherapy treatment. Alternate hypothesis: There is no significant effects of dry needling with conventional physiotherapy treatment as compared to Kinesio Taping with conventional physiotherapy treatment. OBJECTIVES: The aim of this study is: * To determine the effects of dry needling in management of mechanical low back pain. * To determine the effects of kinesio taping in management of mechanical low back pain. * To determine the quality of life in patient with mechanical low back pain. * To determine the varying degree of disability measure in patient with mechanical low back pain. MATERIAL AND METHODS 3.1. Study Design Study will be a randomized control trial (RCT). 3.2. Settings The study will be conducted in the Rawal General and Dental Hospital Islamabad and Al-Nafees hospital Islamabad. 3.3. Duration of Study The duration of study will be completed in 04 months after approval of synopsis. 3.4. Sample Size Thirty patients will be enrolled in the study. Patients will be divided into groups i.e; 15 patients in each group 3.5. Sampling Technique Non probability convenient sampling. 3.6. Assessment: A pre-intervention assessment will be performed to each participant before they will be randomly assigned to kinesio taping group or dry needling group with physical therapy intervention and outcome measures will be recorded before the intervention i.e; baseline assessment ,after 2 weeks of intervention and after four weeks of treatment. After treatment, patients will be performed post-intervention assessment. 3.7. INTERVENTION: Participants will be divided into two groups Group 1: control group in which kinesiotaping with conventional physical therapy treatment (modalities including transcutaneous electrical nerve stimulation (TENS); electrical muscle stimulation (EMS); and interferential current (IFC). Physical agents including ultrasound, hot packs, and cold packs. Exercise including McKenzie exercises) will be administered. Group 2: experimental group in which dry needling with conventional physical therapy treatment modalities including transcutaneous electrical nerve stimulation (TENS); electrical muscle stimulation (EMS); and interferential current (IFC). Physical agents including ultrasound, hot packs, and cold packs. Exercise including McKenzie exercises) will be administered. 3.8. Treatment plan: There will be a 4 weeks treatment plan consisting of 12 sessions. On each week 3 sessions will be conducted.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Adeela Asad
Islamabad, Federal Capital, Pakistan
Start Date
July 1, 2021
Primary Completion Date
August 1, 2021
Completion Date
September 1, 2021
Last Updated
July 26, 2021
30
ESTIMATED participants
dry needle
DEVICE
Lead Sponsor
Shaheed Zulfiqar Ali Bhutto Medical University
NCT07403292
NCT06810128
NCT06578208
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions